Enveda reaps 311m round feed its ambition become household name

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 24 Sept, 12:07 UTC

Enveda has raised a $311 million series E round, positioning the nature-derived drug discovery company to pursue its goal of becoming a household name over the next decade.

businessscience

Sources

• T2Enveda reaps 311m round feed its ambition become household nameFierce Biotech / Fierce Healthcare / MedCity / GEN24 Sept, 12:07